NTLA
Intellia Therapeutics, Inc. · Healthcare
EVP and Chief Scientific Officer Laura Sepp-Lorenzino sold $3.6M of Intellia Therapeutics, Inc.
Sold$3,594,357
$138.24Price
26,000Shares
−92%Stake
What NTLA did after the filing
- The stock from Fri, Aug 6 close, $167.31
- −11.3%
- S&P 500, same days
- −1.6%
Measured over 30 trading days, to the Sep 20 close.
Traded Wed, Aug 4. Filed Fri, Aug 6, 2:19 PM ET, during the session. Returns use the Aug 6 close and the Sep 20 close. Not investment advice.